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ABSTRACT
The CRISPR-Cas (clustered regularly interspaced short palindromic repeats/CRISPR-associated genes) system provides
prokaryotic cells with an adaptive and heritable immune response to foreign genetic elements, such as viruses, plasmids,
and transposons. It is present in the majority of Archaea and almost half of species of Bacteria. Porphyromonas gingivalis is an
important human pathogen that has been proven to be an etiological agent of periodontitis and has been linked to systemic con-
ditions, such as rheumatoid arthritis and cardiovascular disease. At least 95% of clinical strains of P. gingivalis carry CRISPR
arrays, suggesting that these arrays play an important function in vivo. Here we show that all four CRISPR arrays present in the
P. gingivalisW83 genome are transcribed. For one of the arrays, we demonstrate in vivo activity against double-stranded DNA
constructs containing protospacer sequences accompanied at the 3= end by an NGG protospacer-adjacent motif (PAM). Most of
the 44 spacers present in the genome of P. gingivalisW83 share no significant similarity with any known sequences, although 4
spacers are similar to sequences from bacteria found in the oral cavity and the gastrointestinal tract. Four spacers match
genomic sequences of the host; however, none of these is flanked at its 3= terminus by the appropriate PAM element.
IMPORTANCE
The CRISPR-Cas (clustered regularly interspaced short palindromic repeats/CRISPR-associated genes) system is a unique sys-
tem that provides prokaryotic cells with an adaptive and heritable immunity. In this report, we show that the CRISPR-Cas sys-
tem of P. gingivalis, an important human pathogen associated with periodontitis and possibly also other conditions, such as
rheumatoid arthritis and cardiovascular disease, is active and provides protection from foreign genetic elements. Importantly,
the data presented here may be useful for better understanding the communication between cells in larger bacterial communi-
ties and, consequently, the process of disease development and progression.
Prokaryotes are well known for their ability to respond dynam-ically to the changing environment by means of genetic alter-
ations (1). In addition, they have developed more sophisti-
cated defensemechanisms against foreign nucleic acids, including
masking, mutating, or downregulating phage receptors (2, 3); in-
terference with phage/plasmid DNA transfer (4, 5); digestion of
nonself DNA by restriction-modification systems (6); and highly
specific degradation of foreign nucleic acids in a sequence-depen-
dent manner by the CRISPR-Cas (clustered regularly interspaced
short palindromic repeats/CRISPR-associated genes) system.
CRISPRs were first discovered in 1987 (7), but their function was
elucidated only recently (8). They have been identified in more
than 80% of Archaea species and about 45% of Bacteria species
(9). The CRISPR-Cas system is the only adaptive and heritable
prokaryotic immune system identified to date (10).
Structurally, a CRISPR-Cas genetic element consists of an ar-
ray of repeats interspaced with relatively short DNA stretches,
called spacers, with a set of cas genes in close proximity (11). The
CRISPR array is located downstream of the leader sequence,
which plays an important role in acquisition of new spacers as well
as transcription of the CRISPR array. Spacers are short sequences
originating from foreign (or sometimes self) nucleic acids that
serve as a memory bank of past infections and events involving
introduction of nucleic acids to the bacterial cell; their presence
enables complementarity-based recognition of nucleic acids and
their subsequent degradation. Sequences complementary to the
spacers in the target nucleic acids are called protospacers. The
exact mechanism of CRISPR-Cas-mediated nucleic acid degra-
dation varies between species. Based on the presence/absence
of particular Cas proteins encoded in the genome, CRISPR-Cas
systems are divided into three major types (types I to III) and
11 subtypes (12). Cas1 and Cas2 proteins are present in all
active systems. The signature protein of type I CRISPR-Cas
systems is Cas3, whose DNase activity is responsible for degra-
dation of target DNA (13). In type II systems, the signature
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protein is Cas9, which contributes to processing of the long
precursor transcript, called the pre-crRNA, degradation of the
targeted nucleic acid (14), and spacer acquisition (15). The
cleavage of pre-crRNA requires trans-activating small crRNA
(tracrRNA), base pairing with the repeat fragment of pre-
crRNA, and the housekeeping protein RNase III (16). Finally,
Cas10 is the signature protein of type III CRISPR-Cas systems,
which are further divided into subtypes III-A and III-B; sub-
type III-A was shown to degrade both DNA and RNA (17, 18),
whereas subtype III-B is RNA specific (19). A detailed descrip-
tion of all CRISPR-Cas types is provided in a recent review
(10).
Periodontitis is the most prevalent infectious inflammatory
disease of humankind; up to 47% of the adult population suffers
from this disease (20, 21). One of the key players in development
of periodontitis is the Gram-negative anaerobic bacterium Por-
phyromonas gingivalis (22). Importantly,P. gingivalis infection has
also been associated with other conditions, including rheumatoid
arthritis, cardiovascular disease, and aspiration pneumonia (23–
25). In silico analysis of three publicly available genomic sequences
of P. gingivalis strains (W83, TDC60, and ATCC 33277), as well as
clinical strains, revealed that at least four differentCRISPR regions
(30, 36.1, 36.2, and 37) and two sets of accompanying cas genes are
present in the P. gingivalis genome (26), including one belonging
to type I-C (neighboring CRISPR 30) and the other belonging to
type III-B (neighboring CRISPR 37).
The RNA produced during transcription of a CRISPR region
(pre-crRNA) is processed by Cas proteins to yield short crRNA
molecules containing spacer sequences, which serve as guides for
subsequent CRISPR-Cas-mediated degradation of nucleic acids
(16, 27). In type I and III CRISPR-Cas systems, pre-crRNA pri-
mary processing is performed by one of the following Cas endo-
nucleases: Cas6, Cas6b, Cas6e, Cas6f, or Cas5d. All of these en-
zymes cleave repeat sequences at a single position, producing
crRNAs containing the complete spacer sequence and fragments
of the repeat sequence at both ends (called 5= and 3= handles). In
most of the characterized type I and III systems, the 5= handle is 8
nucleotides (nt) long, whereas the 3= handle contains the rest of
the repeat sequence (19, 27–31). Some exceptions exist, however,
such as the type I-C system, in which the 5= handle is 11 nt long
(30). Another example is the Synechocystis sp. system, with a 5=
handle of 13 nt (32). In some bacterial species, crRNA is further
trimmedduringmaturation. In Staphylococcus epidermidis (which
has a type III-A CRISPR-Cas system), this process yields two ma-
ture crRNA species, of 43 nt and 37 nt, by 3=-side trimming of
crRNA (33). In Streptococcus pyogenes (with a type II system),
crRNAs are cleaved from the 5= side, yielding 39- to 42-nt ma-
ture crRNAs (16). In Pyrococcus furiosus (with at least seven
CRISPR loci and cas genes characteristic of type I-A, I-B, and III-B
systems), crRNAs are cleaved from the 3= side, yielding 45-nt and
39-nt mature crRNAs (19). In type I and III CRISPR-Cas systems,
trimming involves only the 3= end, and the original 5= handle is
preserved (19, 33). However, transcriptmaturation is not the only
means of crRNA generation. In Neisseria spp., in addition to reg-
ular type II processing, the crRNAs are also transcribed separately
from promoters embedded within repeat sequences and then
trimmed (34).
Alignment of protospacer flanking sequences in genetic el-
ements targeted by type I and II CRISPR-Cas systems led to the
identification of conserved sequence motifs, called proto-
spacer-adjacent motifs (PAMs), which are required for spacer
uptake and for CRISPR interference (35, 36). The presence of
PAMs allows for easy discrimination between foreign DNA and
genomic CRISPR loci. The data obtained so far suggest that
type I systems require a PAM at the 3= end of the protospacer
(defining the protospacer as a sequence complementary to but
not identical to the crRNA), whereas type II systems require a
PAM at the 5= end of the protospacer (10, 35, 36). Type III
CRISPR-Cas systems seem not to require PAM elements for
sequence recognition. Instead, the lack of complementarity be-
tween the 5= handle of the mature crRNA molecule and the
target sequence enables the cleavage process and prevents the
system from cleaving its own CRISPR array (37).
For the present study, we assessed the activity of the CRISPR-
Casmodules inP. gingivalis strainW83. The results clearly showed
that all CRISPR loci are transcribed and that at least some tran-
scripts are processed to form crRNAs. Furthermore, the CRISPR-
Cas system was able to mediate degradation of plasmids contain-
ing elements complementary to the spacers. Functional analysis
indicated that protospacer flanking sequences are important for
recognition of the target sequence.
MATERIALS AND METHODS
In silico analysis.CRISPR regions present in P. gingivalis strainW83were
identified using CRISPRfinder and the CRISPR database (9, 38). The cas
genes were previously annotated by Watanabe et al. (26). Individual
spacer sequences present in four identified CRISPR arrays were used to
search for potential protospacer sequences by using CRISPRTarget (39).
Consensus repeat sequences for each of the identified CRISPR arrays were
used to search the CRISPRmap database to identify structural motifs and
sequence families (40).
Bacterial culture. P. gingivalisW83was grown anaerobically in tryptic
soy broth (Fluka, Switzerland) supplemented with 0.5% yeast extract
(Bioshop, Canada), L-cysteine (0.5mg/ml; Bioshop, Canada), menadione
(0.5 g/ml; ICN Biomedicals), and hemin (5 g/ml; ICN Biomedicals).
For agar plates (henceforth called blood agar plates), mediumwas supple-
mented with 5% sheep blood and 1.5% agar. Tetracycline (1 g/ml) and
gentamicin (150 g/ml) were added if required. All cultures were pro-
cessed in an MACS500 anaerobic chamber (Don Whitley Scientific Lim-
ited, Frederick,MD) in an atmosphere of 80%N2, 10%CO2, and 10%H2.
Bacterial stocks were stored at 80°C in storage medium (culture me-
dium supplemented with glycerol). For preparation of liquid cultures,
bacterial stocks were first cultured on blood agar plates, and selected col-
onies were used to inoculate the broth (seed cultures). After overnight
growth, the required volume of fresh broth was inoculated with a seed
culture to an optical density at 550 nm (OD550) of 0.1 and grown anaer-
obically at 37°Cuntil the desiredOD550was reached.Escherichia coli strain
S17-1 was purchased from Leibniz-Institut DSMZ. All E. coli strains were
grown aerobically in LB medium (Bioshop, Canada) with shaking. If re-
quired, ampicillin (100 g/ml) was added.
Purification of nucleic acids. Total RNA of P. gingivaliswas extracted
using Tri reagent (Sigma-Aldrich, Poland) as indicated by the manufac-
turer, with modifications. Briefly, 10 ml of P. gingivalis culture was cen-
trifuged at 3,000 g for 30min, and the pellet was resuspended in 1ml of
Tri reagent. After 5 min of incubation at room temperature, 0.2 ml of
chloroform was added, and the sample was shaken vigorously and incu-
bated for 10 min at room temperature. The resulting mixture was centri-
fuged (12,000 g for 15 min at 4°C). The aqueous phase was transferred
to a new tube, and RNAwas precipitated with 0.5 ml of 2-propanol (16 h,
20°C). Subsequently, RNA was pelleted by centrifugation (12,000  g
for 10 min at 4°C) and washed with 1 ml of 75% ethanol. Dried RNA was
resuspended in 50 l of sterile, nuclease-free water (Sigma-Aldrich, Po-
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land). Isolated RNA was quantified using a NanoDrop spectrophotome-
ter (Thermo Scientific) and stored at80°C.
Plasmids from E. coli and P. gingivalis were purified using a GeneJET
plasmid miniprep kit (Thermo Scientific) as indicated by the manufac-
turer.
P. gingivalis genomicDNAwas purifiedusing a genomicminikit (A&A
Biotechnology, Poland) according to a protocol provided by the manu-
facturer.
Northern blot analysis. P. gingivalis total RNAwas isolated from bac-
teria after 24 h of culture to an OD600 between 1.6 and 1.7. Samples were
treated with Turbo DNase (Life Technologies) according to themanufac-
turer’s instructions. Total RNA (15g) was separated in a 15% polyacryl-
amide gel (19:1 acrylamide-bis) supplemented with 8M urea. The gel was
prerun at 180 V for 30 min. Samples were separated at 100 V until they
completely entered the gel and afterwards at 180V. RNAswere transferred
to a nylon membrane (Immobilon-Ny; Millipore) by use of a Trans-
Blot SD semidry transfer cell (Bio-Rad) andwere fixedwith aHoeferUVC
500 UV cross-linker (Hoefer) set to 70,000 J/cm2. Following cross-link-
ing, themembrane was prehybridized in Perfect Hyb hybridization buffer
(Sigma-Aldrich, Poland) for 5 min at 42°C. Furthermore, the hybridiza-
tion buffer was supplemented with the biotinylated probes listed in Table
1. The overall scheme of annealing places for probes is presented in Fig.
1B. The membrane was incubated overnight at 42°C in a hybridization
oven (Micro-4; Hybaid, United Kingdom). The signal was visualized us-
ing a biotin chromogenic detection kit (Thermo Scientific) as indicated by
themanufacturer. A small RNAmarkerwas purchased fromAbnova (Tai-
wan). In addition, two RNA fragments obtained by in vitro transcription,
with lengths of 30 and 50 bases, were used. In vitro transcription was
performed using anmMESSAGEmMACHINET7 kit (Life Technologies)
according to the manufacturer’s instructions. Two oligonucleotides (5=-
AAT AAA GCA GAT TGG GAA AAT CCT ATA CCC TAT AGT GAG
TCG TAT TA-3= and 5=-TAT CGT GCT GTA AAT AAA GCA GAT TGG
GAA AAT CCT ATA TGT ACT TTC CCT ATA GTG AGT CGT ATT
A-3=) containing the T7 promoter sequence were used as templates. Both
fragments encoded transcripts recognized by the probe CRISPR 30 spacer
20 in order to allow detection on a Northern blot membrane.
Construction of plasmids containing protospacers.The shuttle plas-
mid pT-COW encodes a TetQ protein (responsible for tetracycline resis-
tance), replicates both in E. coli and in P. gingivalis, and can be delivered
efficiently into P. gingivalis cells via conjugation with E. coli S17-1 (41).
The shuttle plasmid pT-COW was kindly provided by Don R. Demuth
(University of Louisville, School of Dentistry). The plasmid was digested
with the HindIII and SalI restriction enzymes (Thermo Scientific) and
gel purified. The DNA fragments listed in Table 2 were synthesized
(Genomed, Poland) and annealed to form double-stranded DNAs
(dsDNAs) with overhanging ends compatible with the linear plasmid
mentioned above. The annealing procedure was performed as follows.
Oligonucleotides (100mol) (Table 2) dissolved in Tris-EDTA (TE) buf-
fer were mixed in appropriate pairs at a 1:1 molar ratio. Samples were
incubated for 3 min at 95°C and cooled at room temperature. Resulting
double-strandedDNAs (50mol) were diluted 100-fold. Twomicroliters
of dilutedDNA (1 pmol)wasmixedwith 50 ng of linear plasmid, ligated
with T4 DNA ligase (Thermo Scientific) as recommended by the manu-
facturer, and used to transform chemically competent E. coliDH5 cells.
The cells were plated on LB agar with ampicillin (100 g/ml). Resulting
bacterial colonies were checked by sequencing, and clones containing ap-
propriate inserts were selected.
Assessment of RNA degradation by the CRISPR-Cas system. In or-
der to determine whether RNA constitutes a substrate for the CRISPR
30/Cas system, a quantitative reverse transcription-PCR (RT-PCR) assay
with a reporter sequence was designed. Briefly, a synthetic reporter cas-
sette was prepared that carried annealing sites for a fluorescent probe and
primers. A BglII restriction site was introduced between primer/probe
annealing sites. Conjugation of the pT-COW plasmid in P. gingivalis re-
TABLE 1 Probes for Northern blot detection of crRNA
Targeted CRISPR and region Probe sequence
CRISPR 36.1
Repeat GTTGGATCTACCCTCTATTCGAAGGGTACACACAAC-biotin
Repeat GTTGTGTGTACCCTTCGAATAGAGGGTAGATCCAAC-biotin
Spacer 4 TCAAGGGTCGGGTTCTTGACCTTACCTCCA-biotin
Spacer 4 TGGAGGTAAGGTCAAGAACCCGACCCTTGA-biotin
CRISPR 36.2
Repeat Biotin-GTTGTCTCCACCCTTCTAACTAAGGGTATTCCCAAC
Repeat Biotin-GTTGGGAATACCCTTAGTTAGAAGGGTGGAGACAAC
Spacer 4 Biotin-GCAATCACAAAAACTTATAACGATGCGTTT
Spacer 4 Biotin-AAACGCATCGTTATAAGTTTTTGTGATTGC
CRISPR 37
Repeat Biotin-GTCTTAATAGCCTTACGGACTGTGTATGTATAGTGAG
Repeat Biotin-CTCACTATACATACACAGTCCGTAAGGCTATTAAGAC
Spacer 4 Biotin-TGCAGGGAGTTGGTTCAGCAAAAACCCCGCTGTC
Spacer 4 Biotin-GACAGCGGGGTTTTTGCTGAACCAACTCCCTGCA
CRISPR 30
Repeat GTTTTAATTCCTGTATGGTGCAATTGAAAT-biotin
Repeat ATTTCAATTGCACCATACAGGAATTAAAAC-biotin
Spacer 1 Biotin-CTCCCGGGTTGGGCAGCACGGCTTTGAGGAATTGG
Spacer 1 Biotin- CCAATTCCTCAAAGCCGTGCTGCCCAACCCGGGAG
Spacer 4 GATTCTCTATATGTTCAGTTCAATACAATGCTGAAA-biotin
Spacer 4 TTTCAGCATTGTATTGAACTGAACATATAGAGAATC-biotin
Spacer 7 Biotin-CTATAAAAGAAATTCCAAGAGAGCATGATTCTGAG
Spacer 7 Biotin- CTCAGAATCATGCTCTCTTGGAATTTCTTTTATAG
Spacer 20 AATAAAGCAGATTGGGAAAATCCTATATGTACTTT-biotin
Spacer 20 AAAGTACATATAGGATTTTCCCAATCTGCTTTATT-biotin
P. gingivalis CRISPR-Cas Systems
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sults in transcription of the plasmidDNA, probably due to the presence of
a cryptic promoter site. A synthetic reporter cassette was cloned into the
pT-COW plasmid by use of BamHI and SalI restriction sites, using T4
DNA ligase (Thermo Scientific) according to the manufacturer’s instruc-
tions. The resulting plasmid was recovered in E. coli DH5 bacteria and
sequenced (Genomed, Poland).
Synthetic protospacers (Genomed, Poland) (Table 2) were introduced
into the plasmid through the BglII restriction site by ligationwithT4DNA
ligase (Thermo Scientific). In order to prevent self-ligation of the plasmid,
the ligation reactionwas done in the presence of 1Uof theBglII restriction
enzyme. Resulting plasmids were recovered in E. coli DH5 bacteria and
sequenced (Genomed, Poland). Each tested protospacer was introduced
in both orientations, while a random sequence was introduced as a con-
trol.
The plasmids were introduced into P. gingivalis via conjugation with
E. coli strain S17-1, as described below. The obtained bacterial colonies
were collected with a sterile loop and used for total RNA extraction with
an RNA extraction kit (Bio Basic, Canada) according to the manufactur-
er’s instructions. RNA samples were digested with Turbo DNase (Life
Technologies, Poland) as indicated by the manufacturer and repurified
using an RNA extraction kit (Bio Basic, Canada). Subsequently, samples
were divided into two sets. In one set, RNAwas reverse transcribed with a
High Capacity cDNA reverse transcription kit (Life Technologies, Po-
land) according to the manufacturer’s protocol. In the second (control)
set, no reverse transcriptase was added. The obtained cDNAs were ana-
lyzed quantitatively by real-time PCR for the presence of the reporter
sequence, using 1 TaqMan universal master mix II, no AmpErase UNG
(Life Technologies, Poland), 900 nM (each) primers (5=-AAA CCT CGT
TGG AAG CGT GT-3= and 5=-CTG TGG AAA ACC TTT GGC ATC-3=),
and 200 nM specific probe labeled with 6-carboxyfluorescein (FAM) and
6-carboxytetramethylrhodamine (TAMRA) (5=-FAM-ATG TTA TTC
AGT GCT TTG GTC CTC GTG AT-TAMRA-3=). Rox was used as a
reference dye. The reactionwasmonitored on amodel 7500 Fast real-time
PCR machine (Applied Biosystems) with the following settings: 2 min at
50°C, 10 min at 92°C, and 40 cycles of 15 s at 92°C and 1 min at 60°C.
Conjugal transfer of plasmids.E. coli strain S17-1was used as a donor
strain to introduce the pT-COW plasmid and its derivatives into P. gingi-
valis by conjugation (42). Plasmids carrying spacer sequences (Table 2)
were transformed into chemically competent E. coli S17-1 cells. Multiple
colonies from each transformation plate were scraped using a sterile loop
FIG 1 (A) Locations of CRISPR arrays and cas genes in the P. gingivalis chromosome. Protein annotation and CRISPR array nomenclature are presented
according to the system of Watanabe et al. (26). The name of each CRISPR contains the length of a single repeat (and a consecutive number, if there are other
arrays with the same repeat length). Arrows indicate the predicted direction of gene transcription. Blocks representing overlapping sequences are shifted
upwards. Regions of the genome not related to the CRISPR-Cas system are omitted. Positions of CRISPR regions in the genome are shown below the axis. (B)
Scheme for analysis of the CRISPR arrays. Probes used in Northern blots are marked with thin arrows above and below the CRISPR arrays. The arrow at the end
of a given CRISPR array indicates the determined direction of transcription. Self-targeting spacers are marked with bold frames.
Burmistrz et al.
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and mixed with P. gingivalis W83 cells prepared in the same manner on
blood agar without antibiotics. The plates were incubated anaerobically at
37°C overnight. Following the incubation, cocultures were collected with
a sterile loop and plated onto blood agar plates with tetracycline (1g/ml)
and gentamicin (150 g/ml). The plates were incubated for 7 to 10 days
under anaerobic conditions at 37°C, and bacterial colonies were counted
following incubation.
5= rapid amplification of cDNA ends (5= RACE). Total RNA was ex-
tracted from P. gingivalis W83 by using Tri reagent (Sigma-Aldrich, Po-
land), digested with Turbo DNase (Life Technologies, Poland) as indi-
cated by the manufacturer, and repurified using an RNA extraction kit
(Bio Basic, Canada). Reverse transcription was conducted using a
primer complementary to a fragment of the 3rd spacer (5=-CGG TCT
ATC TCG TAG CGT TC-3=) by using a High Capacity cDNA reverse
transcription kit (Life Technologies, Poland) according to the manu-
facturer’s protocol. The remaining RNA was digested with RNase H
and RNase T1 (both from Thermo Scientific) in 50 l RNase H buffer
(both added at 1 U per 10l of reverse transcription reactionmixture).
The resulting pool of cDNAs was purified using a GeneJET PCR puri-
fication kit (Thermo Scientific), and a poly(C) tail was added using
terminal deoxynucleotidyltransferase (Thermo Scientific) according
to the manufacturer’s protocol. The obtained cDNAs were PCR am-
plified using primers complementary to the 2nd primer and the
poly(C) tail (5=-GAG GAG ATA GGA CTC GCG CT-3= and 5=-GGC
CAC GCG TCG ACT AGT ACG GGG GGG GGG GGG IIG-3=, respec-
tively). Amplification products were cloned into the pTZ57R/T plas-
mid by using an InsTAclone PCR cloning kit (Thermo Fisher Scien-
tific) and then sequenced.
RESULTS
CRISPR elements in the P. gingivalis genome. There are four
CRISPR regions in the genome of P. gingivalisW83, two of which
are accompanied by a cluster of cas genes (9, 26, 43). The genomic
organization of these elements is presented in Fig. 1.
Ribonucleases cleaving pre-crRNAs into crRNAs recognize
the direct repeat sequences, and even slight modifications of
these elements may prevent cleavage (44, 45). Analysis of the P.
gingivalis CRISPR regions revealed that the repeats are well con-
served within each of the four arrays, yet their sequences differ
between arrays (Table 3). CRISPRs 36.1 and 36.2 exhibit the high-
est level of conservation: all repeats within these arrays are identi-
cal. Two other CRISPR regions are slightly less conserved. In
CRISPR 37, there is a single-nucleotide difference in themiddle of
the penultimate repeat, and in CRISPR 30, there is a single-nucle-
otide variation at the end of the last repeat. Furthermore, the re-
peats of CRISPRs 36.1 and 36.2 share 72% identity (26 of 36 nt are
identical) (Table 3). The CRISPRmap analysis assigned CRISPRs
36.1 and 36.2 into superclass F, without identifying the sequence
family or structuralmotif. CRISPR 30was assigned into superclass
A in family sequence 2, without identifying the structural motif.
For CRISPR 37 of superclass E, no family sequence was assigned,
but it was assigned to structural motif 4.
Spacer sequences in CRISPR arrays are essential for recogni-
tion of the target nucleic acids. These elements are introduced into
TABLE 2 Oligonucleotides used for construction of plasmids containing protospacers
Plasmid Oligonucleotide sequencea
sp4_AAA/TTT AGCTaaaTTTCAGCATTGTATTGAACTGAACATATAGAGAATCaaa
TCGAtttGATTCTCTATATGTTCAGTTCAATACAATGCTGAAAttt
sp4 CCT/TTT AGCTcctTTTCAGCATTGTATTGAACTGAACATATAGAGAATCaaa
TCGAtttGATTCTCTATATGTTCAGTTCAATACAATGCTGAAAagg
sp4 AAA/AGG AGCTaaaTTTCAGCATTGTATTGAACTGAACATATAGAGAATCagg
TCGAcctGATTCTCTATATGTTCAGTTCAATACAATGCTGAAAttt
sp5 AAA/TTT AGCTaaaAAAGTTTTAAGATTAGCAAACATTTTACCATCTTGTaaa
TCGAtttACAAGATGGTAAAATGTTTGCTAATCTTAAAACTTTttt
sp5 CCT/TTT AGCTcctAAAGTTTTAAGATTAGCAAACATTTTACCATCTTGTaaa
TCGAtttACAAGATGGTAAAATGTTTGCTAATCTTAAAACTTTagg
sp5 AAA/AGG AGCTaaaAAAGTTTTAAGATTAGCAAACATTTTACCATCTTGTagg
TCGAcctACAAGATGGTAAAATGTTTGCTAATCTTAAAACTTTttt
sp4scr AAA/TTT AGCTaaaAGACCTTGCAAGTATATTTGAAACGACTTATTGATAaaa
TCGAtttTATCAATAAGTCGTTTCAAATATACTTGCAAGGTCTttt
sp4scr CCT/TTT AGCTcctAGACCTTGCAAGTATATTTGAAACGACTTATTGATAaaa
TCGAtttTATCAATAAGTCGTTTCAAATATACTTGCAAGGTCTagg
sp4scr AAA/AGG AGCTaaaAGACCTTGCAAGTATATTTGAAACGACTTATTGATAagg
TCGAcctTATCAATAAGTCGTTTCAAATATACTTGCAAGGTCTttt
RNA random seq. GATCCGCGTCTCCTTGCGGGTAGATCGCCGACCGCAGAG
GATCCTCTGCGGTCGGCGATCTACCCGCAAGGAGACGCG
RNA C30/sp4 (/) GATCCGATTCTCTATATGTTCAGTTCAATACAATGCTGAAAG
GATCCTTTCAGCATTGTATTGAACTGAACATATAGAGAATCG
a Lowercase letters indicate PAM sequences.
P. gingivalis CRISPR-Cas Systems
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the genome during an adaptive response to endogenous or exog-
enous nucleic acids. The origin of P. gingivalis W83 spacers re-
mains largely unknown; most of them are not similar to any
known sequence, but four of them exhibit significant degrees of
similarity to the bacterium’s own genomic sequence. The first
leader-proximal spacer of CRISPR 37 matches an intergenic re-
gion in the P. gingivalis W83 genome (36/36 nt; positions 975677
to 975712). The first two leader-proximal spacers of CRISPR 30
share 100% identity with two different regions of the gene encod-
ing saccharopine dehydrogenase (35/35 nt; positions 728442 to
728476 and 728638 to 728672). Finally, the last spacer of CRISPR
30 matches a gene encoding an outer membrane efflux protein
(positions 729776 to 729811); however, in this case, the identity is
not complete (34 of 36 nt). Moreover, none of the four identified
protospacers in the P. gingivalis genome is neighbored by an iden-
tified PAM. Visualization of the self-targeting spacer alignment is
presented in Fig. S1 in the supplemental material. CRISPRTarget
analysis performed for all spacers from the four CRISPR arrays
resulted in hits from other bacterial species that can be found in
the oral cavity and gastrointestinal tract. Hits were noted for spac-
ers 1, 2, 5, and 11 of CRISPR 30. Spacers 1 and 2 showhomology to
sequences encoding saccharopine dehydrogenases (Prevotella spp.
and Bacteroides spp.). Spacer 5 shows homology to sequences en-
coding the beta subunit of acetyl coenzyme A (acetyl-CoA) car-
boxylase (Streptococcus agalactiae) and PtrB protease (Flavobacte-
ria spp.). The results for spacer 11 indicate homology to sequences
encoding an ABC transporter permease (Butyrivibrio spp.) and
sequences that are not associated with open reading frames (Leu-
conostoc inhae and Bacillus cereus). However, the differences be-
tween all of these spacers and identified sequences are consider-
able, ranging from 3 to 8 nt.
CRISPR loci are transcriptionally active. Northern blotting
using biotinylated probes specific to repeats and spacers in the
CRISPR cassettewas used to detect transcripts containingCRISPR
elements (Fig. 2). This analysis revealed that CRISPRs 36.2, 37,
and 30 are transcribed in the same direction (consistent with the
transcription direction of cas genes), whereas CRISPR 36.1 is tran-
scribed in the opposite direction. For some probes, however
(CRISPR37 spacer 4 andCRISPR36.2 repeat), bandswere present
for both possible directions of transcription. This may indicate
bidirectional transcription of crRNAs.
Analysis of total bacterial RNA with probes specific to both
spacers and repeats revealed the presence of a distinct product of
70 bases, corresponding in size to an RNAmolecule containing
a single spacer-repeat tandem, in all four CRISPR arrays (expected
lengths, 66 nt for CRISPRs 36.1 and 36.2, 64 to 67 nt for CRISPR
30, and 71 to 75 nt for CRISPR 37). Additional bands present for
each CRISPR array, with lengths exceeding 100 nt, correspond to
double tandem units consisting of two spacers and two repeats.
The results obtained for CRISPR 30 suggest that crRNAmolecules
originating from different spacers may be processed differently.
The signal for spacer 1wasweak, but anRNA fragment of about 70
nt (which corresponds in length to the single repeat-spacer unit)
could be observed. For spacer 4, in addition to the 70-nt RNA
fragment, three additional RNA fragments were present (60 nt,
slightly larger than 40 nt, and slightly smaller than 40 nt). For
spacer 7, there was an 70-nt fragment accompanied by two
smaller RNA molecules, which were slightly larger and slightly
TABLE 3 Basic characteristics of CRISPR arrays in the P. gingivalis W83 genome
CRISPR
array Repeat consensus sequence
No. of
spacers
Spacer
length (nt)
Putative associated
CRISPR-Cas type
36.1 GTTGGATCTACCCTCTATTCGAAGGGTACACACAAC 7 30 Unknown
36.2 GTTGTCTCCACCCTTCTAACTAAGGGTATTCCCAAC 7 30 Unknown
37 GTCTTAATAGCCTTACGGACTGTGTATGTATAGTGAG 7 34–38 III-B
30 GTTTTAATTCCTGTATGGTGCAATTGAAAT 23 34–37 I-C
FIG 2 Northern analysis of CRISPR array transcription. Total RNA of P. gingivalisW83 was separated in a 15% polyacrylamide gel containing 8 M urea; RNAs
were transferred to nylon membranes by electroblotting and analyzed using biotinylated synthetic DNA probes specific to repeat and spacer sequences. “”
probes have a direction consistent with the direction of cas gene transcription (identical for all). “” probes are complementary to “” probes. Arrows to the
right of each gel indicate the expected sizes of crRNA processing products, as follows: crRNA, mature crRNA; 1, single repeat-spacer unit; and 2, double
repeat-spacer unit.
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smaller than 40 nt. In this case, the 60-nt product was not visible.
For spacer 20, a single crRNA was visible, although no additional
bands were detected. All probes specific to the repeats and two
probes specific to the spacers (CRISPR 36.1 spacer 4 and CRISPR
30 spacer 4) recognized products of pre-crRNA scission that were
approximately 70 nt long. The probe specific to the CRISPR 36.1
repeat recognized RNA molecules smaller than 70 nt.
To determine the transcription start site for the CRISPR 30
array, we used 5= RACE. Most of the RNAs originating from the
CRISPR 30 region reached only the first repeat of the array (ex-
actly 8 nt from its 3= end). RT-PCR analysis revealed the presence
of longer CRISPR 30 transcripts, stretching at least 84 nt beyond
the first repeat (data not shown). The 5= RACE technique con-
firmed the scission of pre-crRNA in the region of the first repeat
sequence, resulting in a product with an 8-nt 5= handle, but un-
fortunately, it failed to reveal the transcription start site.
Specificity and activity of the CRISPR 30 machinery. No
knownphages infectP. gingivalis. Therefore, to evaluate the in vivo
activity, specificity, and effectiveness of the P. gingivalis CRISPR-
Cas system, we constructed artificial mobile genetic elements
(plasmids) based on the shuttle vector pT-COW (37). To assess
whether the CRISPR-Cas system is active in P. gingivalis, a single
CRISPR cassette (CRISPR 30) was selected for detailed analy-
sis. This decision was motivated by the fact that two of the
CRISPR loci (CRISPR 36.1 and CRISPR 36.2) lack cas genes
and the third locus (CRISPR 37) is of type III-B, which targets
RNA rather than DNA.
To assess whether the CRISPR-Cas system is able to specif-
ically degrade dsDNA, pT-COW-derived plasmids carrying se-
quences complementary to crRNA (originating from CRISPR
30) flanked by various adjacent sequences were delivered into
P. gingivalis by conjugation. These sequences included spacers 4
and 5 (counting from the leader end of the array), as well as a
scrambled spacer with the nucleotide content of spacer 4, but with
a randomized sequence to avoid similarity to any spacer of the
studied array. Each of the aforementioned protospacers was pre-
pared in three variants: with the predicted PAMat the 5= end, with
the predicted PAM at the 3= end, and with no PAM at all. The
results clearly show that dsDNA may be a target of the CRISPR
30/Cas module and that bacteria conjugated with plasmids carry-
ing sequences complementary to crRNAs with the appropriate
flanking regions were not able to survive in the presence of tetra-
cycline (Fig. 3).
The choice of sequences adjacent to the protospacer selected
for testing was based on data reported in the literature. CRISPR
arrays can be grouped into at least 12 clusters according to repeat
sequence similarity (46). CRISPR 30 belongs to cluster 1; there-
fore, the CRISPR 30/Cas system is predicted to recognize theNGG
sequence as a PAM (35). In the aforementioned publication, the
direction of transcription of CRISPR regions was not verified in
vivo, so it is possible that the exact PAM sequence is CCN at the 5=
end of the protospacer or NGG at the 3= end. For the no-PAM
variant, the sequences 5=TTT and 3=AAAwere chosen because no
single-base trinucleotides are expected to trigger interference (Ta-
ble 4).
Delivery of plasmids containing protospacers from the
CRISPR 30 array reduced the number of surviving bacteria for
variants containing the proper protospacer sequence flanked by a
putative PAM sequence at the 3= end, namely, sp4 TTT/AGG (P
0.05) and sp5 TTT/AGG (P 0.05) (Fig. 3). For all other variants,
including a randomized spacer with a PAMsequence at the 3= end,
no statistically significant difference was observed relative to the
parental plasmid.
Some CRISPR-Cas modules are also able to process RNA tar-
gets; these include CRISPR-Cas type III-B, which was detected in
the genome of P. gingivalis W83. To exclude the possibility of
CRISPR 30 involvement in type III-B immunity, we tested its
FIG 3 Protospacer-adjacent sequences are important for CRISPR-Cas-medi-
ated target degradation. The plasmid pT-COW and its derivatives were deliv-
ered to P. gingivalisW83 via conjugation. The name of each plasmid contains
the number of the spacer introduced into the plasmid and the three-nucleotide
5= and 3=flanks of the protospacer. The significance of the observed differences
between samples and the control plasmid was analyzed using Student’s t test.
All experiments were repeated three times, and results are expressed as means
	 standard deviations (SD).
TABLE 4 Sequences of protospacer regions of pT-COW derivatives used for conjugation assaya
Plasmid
5=-end-adjacent
sequence Protospacer sequence (5=–3=)
3=-end-adjacent
sequence
sp4_TTT/AAA TATTCGATTT GAT TCT CTA TAT GTT CAG TTC AAT ACA ATG CTG AAA AAAAGCTGGC
sp4 CCT/AAA TATTCGACCT GAT TCT CTA TAT GTT CAG TTC AAT ACA ATG CTG AAA AAAAGCTGGC
sp4 TTT/AGG TATTCGATTT GAT TCT CTA TAT GTT CAG TTC AAT ACA ATG CTG AAA AGGAGCTGGC
sp5 TTT/AAA TATTCGATTT ACA AGA TGG TAA AAT GTT TGC TAA TCT TAA AAC TTT AAAAGCTGGC
sp5 CCT/AAA TATTCGACCT ACA AGA TGG TAA AAT GTT TGC TAA TCT TAA AAC TTT AAAAGCTGGC
sp5 TTT/AGG TATTCGATTT ACA AGA TGG TAA AAT GTT TGC TAA TCT TAA AAC TTT AGGAGCTGGC
sp4scr TTT/AAA TATTCGATTT TAT CAA TAA GTC GTT TCA AAT ATA CTT GCA AGG TCT AAAAGCTGGC
sp4scr CCT/AAA TATTCGACCT TAT CAA TAA GTC GTT TCA AAT ATA CTT GCA AGG TCT AAAAGCTGGC
sp4scr TTT/AGG TATTCGATTT TAT CAA TAA GTC GTT TCA AAT ATA CTT GCA AGG TCT AGGAGCTGGC
a Nucleotides in bold indicate PAM sequences.
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spacers by RNA interference. Because the crRNA-mediated RNA
cleavage of type III-B is not dependent on the presence of PAMs
(47), no alternative protospacer-adjacent sequences were intro-
duced. Plasmids designed for expression of the reporter RNA,
containing spacer 4 from CRISPR 30 in both orientations, were
introduced into P. gingivalis by conjugation, and then the levels of
the produced RNAwere assessed by quantitative RT-PCR (Fig. 4A
and B). The levels of RNA containing potential targets for the
CRISPR 30/Cas system were not affected compared to that of the
control random RNA.
DISCUSSION
The presence of CRISPR genetic elements in the majority of clin-
ical P. gingivalis strains and their structural conservation (26) sug-
gest that they play an essential role in bacterial survival. To date,
however, no phages able to infectP. gingivalishave been identified,
and this species has no known naturally occurring plasmids (48,
49). Hence, the main function of this system remains uncon-
firmed. A recent report on P. gingivalis DNA-exchange mecha-
nisms revealed that this bacterium is naturally competent and that
DNA uptake is not sensitive to the DNA source or modification
status (50). Given that extracellularDNA is a common constituent
of bacterial biofilms (51–53), the CRISPR-Cas system may have
evolved as a protective system that verifies and selects DNA mol-
ecules entering bacterial cells, helping to regulate horizontal gene
transfer. The results of CRISPRTarget analysis, which revealed
some degree of similarity between specific spacers of CRISPR 30
and sequences from bacteria found in the oral cavity and gastro-
intestinal tract, support this hypothesis.
Two different sets of cas genes, characteristic of the CRISPR-
Cas I-C and III-B systems, are present in the P. gingivalis W83
genome (12, 26). In both of these systems, the primary processing
of pre-crRNA results in formation of immature crRNAs contain-
ing a 5= handle (11 nt in type I-C and 8 nt in type III-B) derived
from the repeat sequence, with the rest of the repeat sequence at
the 3= end (27–30). In type III-B, secondary processing is per-
formed by an unknown nuclease that trims the 3= end. Four
CRISPR arrays are present in the P. gingivalisW83 genome (9, 43).
Here we showed that all these regions are transcribed and pro-
cessed to form single repeat-spacer crRNA units, consistent with
previous reports (54). Furthermore, some of these units seem to
be transcribed bidirectionally. Such RNA species were also iden-
tified in Sulfolobus solfataricus (55). It was hypothesized that these
small cRNAs can neutralize crRNAs in the absence of invading
nucleic acids. Another proposed explanation for this phenome-
non is that transcription in the reverse orientation relative to that
of spacer elements is specific to organisms with a relaxed tran-
scription start site rather than a feature of the CRISPR-Cas system
itself (31). Employment of probes specific for spacers and repeat
sequences allowed visualization of repeat-spacer tandem units for
CRISPR 37 (spacer 4) and CRISPR 30 (spacers 4 and 7). However,
we also observed smaller-than-predicted products. For CRISPR
FIG 4 (A) Scheme of CRISPR 30 RNA interference experiment. The pT-
COW plasmid was supplemented with a synthetic reporter sequence con-
taining a protospacer variant together with a nucleotide probe annealing
site flanked by PCR priming sites. Introduction of the modified plasmid
into P. gingivalis results in transcription of the reporter cassette, which is a
potential target for CRISPR RNA interference. This interference results in a
decrease of transcript levels, which can be detected by quantitative RT-PCR
analysis. (B) Degradation of RNA by the CRISPR 30/Cas system. The graph
shows numbers of RNA copies in bacteria conjugated with plasmids carrying
the reporter cassette with protospacers. Reporter, plasmid carrying the re-
porter cassette; random seq., plasmid carrying the reporter cassette with a
random sequence inserted into the region targeted by the real-time PCR prim-
ers and probe; C30/sp4, plasmid carrying the reporter cassette with a se-
quence identical to that of the corresponding crRNA inserted into the region
targeted by the real-time PCRprimers and probe; C30/sp4, plasmid carrying
the reporter cassette with a sequence complementary to that of the corre-
sponding crRNA inserted into the region targeted by the real-time PCR prim-
ers and probe. The significance of the observed differences between samples
and positive-control samples was analyzed using Student’s t test. ns, not sig-
nificant (P
 0.05). All experiments were repeated three times, and the results
are expressed as means	 SD.
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37, which belongs to type III-B, the obtained band pattern fits the
results available for P. furiosus (66- to 72-nt intermediate bands
and two mature crRNA populations, of 39 nt and 45 nt) (19, 47).
In contrast, the band pattern for spacers 4 and 7 of CRISPR 30 fits
the data available for type I-C, inwhich themature formof crRNA
correlates in size with a single repeat-spacer unit (30). The pres-
ence of additional bands may be the result of unspecific cleavage;
notably, the band pattern for spacer 20, which lacks the additional
bands, fits the I-C system model.
Formation of crRNA itself does not define its function and
activity; therefore, an effort wasmade to confirm the functionality
of the CRISPR-Cas system in P. gingivalis. The CRISPR 30 cassette
was selected for detailed characterization due to its proximity to
the cas gene cluster and confirmed crRNA transcription. The re-
sults confirmed that the system is functional: introduction of the
properly flanked protospacer to foreign DNA resulted in its spe-
cific degradation. The protein composition of the products of the
adjacent cas gene cassette and the structure of the repeats follow
the pattern typical for a type I-C system. However, to exclude the
possibility that CRISPR 30 crRNAs target RNA, we verified the
specificity of the system for the RNA substrate. It is important that
cmr genes present in the genome of P. gingivalis W83 may coop-
erate with another CRISPR array; alternatively, the cmr module
may not be functional (the genome of P. gingivalis W83 lacks the
cmr1 gene, whose product is essential for the activity of the Cmr
protein complex [19]). As expected, we observed no CRISPR 30-
mediated degradation of RNA.
Based on their repeat sequences, CRISPR arrays were allocated
into 12 clusters (46), and P. gingivalis CRISPR 30 was assigned to
cluster 1. In silico analysis suggested that in this cluster, the pre-
ferred PAM sequence is NGG; however, previous work showed
that this rule is not absolute (35, 56, 57). Our results indicate that
NGG is an active PAM when it is located at the 3= end of a proto-
spacer (Fig. 3).
The presence of self-targeting spacers may represent the after-
math of an autoimmune event. This idea is supported by the fact
that none of the protospacers within the P. gingivalisW83 genome
are flanked by experimentally determined PAM sequences, which
are required for interference. Mutations within PAMs are among
the ways that bacteria avoid CRISPR-Cas-based autoimmunity
(58).
To summarize, we showed here that all four CRISPR regions
present in theP. gingivalisW83 genome are transcribed and that at
least one of them is active against dsDNA in vivo. The recognition
of the protospacer is mediated by the presence of PAM elements.
Together, the results of this and previous studies suggest that the
P. gingivalis CRISPR-Cas system is highly efficient and may play
an important role in protection against foreignDNAor regulation
of physiological processes.
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